A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early ...

Pre-biopsy MRIs can help doctors diagnose and treat prostate cancer more accurately. Here’s when you should get one.

Data from the SEER and MUSIC registries found a decrease in prostatectomies in those with pathologic grade group 1 prostate cancer. This shift is attributed to evidence supporting active surveillance ...

Researchers from around the U.K., led by the University of Oxford, have found that a new way of performing prostate biopsies is better at diagnosing prostate cancer, but takes longer to perform and is ...

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly.

A 64-year-old long-distance runner, Todd Elworthy was alarmed and confused when his routine prostate specific antigen (PSA) test was elevated in 2023, and a biopsy came back positive for prostate ...

The Gazette offers audio versions of articles using Instaread. Some words may be mispronounced. This story first appeared in Healthy You - April 2025, The Gazette’s quarterly health publication.

A new study reveals that some men who are diagnosed with "Grade Group one" (GG1) prostate cancer may actually be at higher risk than biopsy results suggest, according to research led by Weill Cornell ...

—Physicians surveyed for a new study said that reports generated by artificial intelligence (AI) were, with a few exceptions, accurate and complete. They could also be modified faster than writing an ...

Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children's Hospital, and four other institutions have devised a novel method to test for prostate cancer using biomarkers ...

Prostate cancer is the second-leading cause of death among American men, killing one in 44. In the United States, 3.3 million men are survivors of prostate cancer, and the risk for developing the ...